Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and 2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid

vatalanib has been researched along with 2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid in 1 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid)		Trials
(2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid)		Recent Studies (post-2010) (2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid)
27642981602

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid (IC50)
Estrogen receptor betaMus musculus (house mouse)10
Epidermal growth factor receptorHomo sapiens (human)1.0267
Tyrosine-protein kinase LckHomo sapiens (human)10
Estrogen receptorMus musculus (house mouse)10
Calcium/calmodulin-dependent protein kinase kinase 2Homo sapiens (human)0.2
NADPH oxidase 4Homo sapiens (human)1.34

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for vatalanib and 2-hydroxy-5-(2,5-dihydrobenzyl)aminobenzoic acid

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007